Prognostic role of copeptin after traumatic brain injury: A systematic review and meta-analysis of observational studies
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Kyu Sun | - |
dc.contributor.author | Cho, Youngsuk | - |
dc.contributor.author | Jang, Bo-Hyoung | - |
dc.contributor.author | Kim, Wonhee | - |
dc.contributor.author | Ahn, Chiwon | - |
dc.contributor.author | Lim, Tae Ho | - |
dc.contributor.author | Yi, Hyeong Joong | - |
dc.date.accessioned | 2022-07-13T05:02:53Z | - |
dc.date.available | 2022-07-13T05:02:53Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2017-10 | - |
dc.identifier.issn | 0735-6757 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/151512 | - |
dc.description.abstract | Purpose Copeptin, the C-terminal portion of provasopressin, has emerged as a novel prognostic marker in neurocritical care, such as in traumatic brain injury (TBI). The aim of this study was to quantitatively assess the prognostic significance of initial plasma copeptin levels in the neurological outcome and mortality after traumatic brain injury. Materials and methods Six relevant studies with data from 552 patients were included in this meta-analysis. Results The plasma copeptin levels were found to be significantly higher in patients who died than in the survivors (standardized mean difference [SMD], 1.80). In the four studies reporting Glasgow outcome scale (GOS) data, patients with unfavorable outcomes had significantly higher copeptin levels than those with favorable outcomes (SMD, 1.62). The plasma copeptin level predicted mortality and unfavorable outcomes (AUC, 0.873; AUC, 0.876). Conclusions The present meta-analysis suggests that early measurement of plasma copeptin levels can provide better prognostic information about the functional outcome and mortality in patients with TBI. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | W B SAUNDERS CO-ELSEVIER INC | - |
dc.title | Prognostic role of copeptin after traumatic brain injury: A systematic review and meta-analysis of observational studies | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Kyu Sun | - |
dc.contributor.affiliatedAuthor | Lim, Tae Ho | - |
dc.contributor.affiliatedAuthor | Yi, Hyeong Joong | - |
dc.identifier.doi | 10.1016/j.ajem.2017.04.038 | - |
dc.identifier.scopusid | 2-s2.0-85019542066 | - |
dc.identifier.wosid | 000415183400012 | - |
dc.identifier.bibliographicCitation | AMERICAN JOURNAL OF EMERGENCY MEDICINE, v.35, no.10, pp.1444 - 1450 | - |
dc.relation.isPartOf | AMERICAN JOURNAL OF EMERGENCY MEDICINE | - |
dc.citation.title | AMERICAN JOURNAL OF EMERGENCY MEDICINE | - |
dc.citation.volume | 35 | - |
dc.citation.number | 10 | - |
dc.citation.startPage | 1444 | - |
dc.citation.endPage | 1450 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Emergency Medicine | - |
dc.relation.journalWebOfScienceCategory | Emergency Medicine | - |
dc.subject.keywordPlus | V-2 RECEPTORS | - |
dc.subject.keywordPlus | BIOMARKERS | - |
dc.subject.keywordPlus | STROKE | - |
dc.subject.keywordPlus | DAMAGE | - |
dc.subject.keywordPlus | DIAGNOSIS | - |
dc.subject.keywordPlus | MORTALITY | - |
dc.subject.keywordAuthor | Traumatic brain injury | - |
dc.subject.keywordAuthor | Copeptin | - |
dc.subject.keywordAuthor | Meta-analysis | - |
dc.subject.keywordAuthor | Prognosis | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0735675717303029?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.